MCK

#148
McKesson Corporation
863.4800 USD
+0.06%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
863.4800
863.4800
Range Annuel
789.9600
999.0000
Changement quotidien
+0.06%
Changement Mensuel
-8.44%
Evolution sur 6 mois
+7.60%
Changement Annuel
+7.60%
Clôture Précédente
862.9550
Open
863.4800
Bid
Ask
Low
863.4800
High
863.4800
Volume
1
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 105.7655 B
  • Employee 51 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry Distribution Médicale
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.67
Price to sales ratio
0.26
Dividends per share
0.82
Dividend yield %
0.62

McKesson Corporation

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

Nouvelles